1,733
Views
9
CrossRef citations to date
0
Altmetric
Invited Article

Isolation and identification of three new chromones from the leaves of Pimenta dioica with cytotoxic, oestrogenic and anti-oestrogenic effects

, , , , , , & show all
Pages 235-244 | Received 03 Dec 2017, Accepted 02 Mar 2018, Published online: 22 Mar 2018

References

  • Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, Rao LV, Habibullah CM, Sechi LA, Ahmed N. 2005. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob. 4:20.
  • Barbacci EG, Pustilnik LR, Rossi AM, Emerson E, Miller PE, Boscoe BP, Cox ED, Iwata KK, Jani JP, Provoncha K, et al. 2003. The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells. Cancer Res. 63:4450–4459.
  • Baselga J, Cortes J. 2005. Epidermal growth factor receptor pathway inhibitors. Cancer Chemother Biol Resp Mod. 22:205–223.
  • Baselga J, Swain SM. 2009. Novel anticancer targets: revisiting ErbB2 and discovering ErbB3. Nat Rev Cancer. 9:463–475.
  • Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. 1999. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 60:210–215.
  • Cha WS, Kim JH, Lee KH, Kwon HJ, Yoon SJ, Chun SS, Choi UK, Cho YJ. 2006. Antioxidative and inhibition activities on Helicobacter pylori of spice extracts. J Korean Soc Food Sci Nutr. 35:315–320.
  • Correa P. 2002. Bacterial infections as a cause of cancer. J Natl Cancer Inst. 95:E3.
  • Cullen BR, Malim MH. 1992. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216:362–368.
  • Davis DD, Díaz-Cruz ES, Landini S, Kim YW, Brueggemeier RW. 2008. Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J Steroid Biochem Mol Biol. 108:23–31.
  • DeNardo DG, Kim HT, Hilsenbeck S, Cuba V, Tsimelzon A, Brown PH. 2005. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. Mol Endocrinol. 19:362–378.
  • Doyle BJ, Frasor J, Bellows LE, Locklear TD, Perez A, Gomez-Laurito J, Mahady GB. 2009. Estrogenic effects of herbal medicines from Costa Rica used for the management of menopausal symptoms. Menopause (New York, NY). 16:748–755.
  • Doyle BJ, Locklear TD, Perez A, Brenes JC, Laurito-Gomez J, Mahady GB. 2007. Natural therapies from Costa Rica for the management of menopause: estrogenic activity in the in vitro ER-CALUX reporter gene assay. FASEB J. 21:572.
  • Figueiredo C, Machado JC, Pharoah P. 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 94:1680–1687.
  • Gardner JD, Brower GL, Voloshenyuk TG, Janicki JS. 2008. Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circul Physiol. 294:H198–H204.
  • Gold EB. 2011. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 38:425–440.
  • Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. 2005. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia menopause (PAM) study. Maturitas. 52:264–276.
  • Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ, STRAW 10 Collaborative Group. 2012. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 19:387–395.
  • Howes MJ, Houghton PJ, Barlow DJ, Pocock VJ, Milligan SR. 2002. Assessment of estrogenic activity in some common essential oil constituents. J Pharm Pharmacol. 54:1521–1528.
  • Ibewuike JC, Ogundaini AO, Ogungbamila FO, Martin M, Gallard J, Bohlin L, Pais M. 1996. Piliostigmin, a 2-phenoxychromone, and C-methylflavonols from Piliostigma thonningii. Phytochemistry. 43:687–690.
  • International Agency for Research on Cancer (IARC). 1994. IARC Working Group on the evaluation of carcinogenic risks to humans, schistomsomes, liver flukes and Helicobacter pylori. Infections with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61; p. 177–201.
  • Kim Y, Mobley JA, Brueggemeier RW. 2003. Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain. Bioorg Med Chem Lett. 13:1475–1478.
  • Kugu K, Ratts VS, Piquette GN. 1998. Analysis of apoptosis and expression of Bcl-2 gene family members in the human and baboon ovary. Cell Death Differ. 5:67–76.
  • Liu SY, Song SX, Lin L, Liu X. 2010. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line. Chemotherapy. 56:101–107.
  • Locklear TD, Doyle BJ, Perez A, Laurito-Gomez J, Brenes JC, Huang Y, Mahady GB. 2007. Alternative therapies from Costa Rica for the management of PMS and dysmenorrhea: Justicia pectoralis Jacq.: mechanisms of action. FASEB J. 21:572.
  • Locklear TD, Doyle BJ, Perez AL, Wicks SM, Mahady GB. 2017. Menopause in Latin America: symptoms, attitudes, treatments and future directions in Costa Rica. Maturitas. 104:84–89.
  • Locklear TD, Huang Y, Frasor J, Doyle BJ, Perez A, Gomez-Laurito J, Mahady GB. 2010. Estrogenic and progestagenic effects of extracts of Justicia pectoralis Jacq., an herbal medicine from Costa Rica used for the treatment of menopause and PMS. Maturitas. 66:315–322.
  • Mahmoud AM, Al-Alem U, Ali MM, Bosland MC. 2015. Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation. J Steroid Biochem Mol Biol. 152:62–75.
  • McDonnell DP, Norris JD. 2002. Connections and regulation of the human estrogen receptor. Science (New York, NY). 296:1642–1644.
  • Michel JL, Mahady GB, Veliz M, Soejarto DD, Caceres A. 2006. Symptoms, attitudes and treatment choices surrounding menopause among the Q'eqchi Maya of Livingston Guatemala. Soc Sci Med. 63:732–742.
  • National Institutes of Health (NIH). 2005. National institutes of health state-of-the-science conference statement: management of menopause-related symptoms. Ann Intern Med. 142(12 Pt 1):1003–1013.
  • Nelson HD. 2008. Menopause. Lancet. 371:760–770.
  • Nozawa T, Suzuki M, Yabuuchi H, Irokawa M, Tsuji A, Tamai I. 2005. Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells. Pharm Res. 22:1634–1641.
  • Obourn JD, Koszewski NJ, Notides AC. 1993. Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry. 32:6229–6236.
  • Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P. 2010. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric. 13:419–428.
  • Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engström O, Ljunggren J, Gustafsson JA, Carlquist M. 1999. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18:4608–4618.
  • Polasek J, Queiroz EF, Marcourt L, Meligova AK, Halabalaki M, Skaltsounis AL, Alexis MN, Prajogo B, Wolfender JL, Hostettmann K. 2013. Peltogynoids and 2-phenoxychromones from Peltophorum pterocarpum and evaluation of their estrogenic activity. Planta Med. 79:480–486.
  • Ribeiro AB, Siqueira Silva DH, da Silva Bolzani V. 2002. Antioxidant flavonol glycosides from Nectandra grandiflora (Lauraceae). Eclética Quím. 27:35–44.
  • Saxena R, Dwivedi A. 2012. ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective. Med Res Rev. 32:166–215.
  • Scheiman JM, Cutler AF. 1999. Helicobacter pylori and gastric cancer. Am J Med. 106:222–226.
  • Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J. 2001. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 96:3406–3410.
  • Tagliaferri MA, Tagliaferri MC, Creasman JM, Koltun WD. 2016. A selective estrogen receptor beta agonist for the treatment of hot flushes: phase 2 clinical trial. J Altern Complement Med (New York, NY). 22:722–728.
  • Treeck O, Weber A, Boester M, Porz N, Frey N. 2003. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231. Breast Cancer Res Treatment. 80:155–162.
  • Warner M, Huang B, Gustafsson JA. 2017. Estrogen receptor β as a pharmaceutical target. Trends Pharmacol Sci. 38:92–99.
  • Youssef DTA, Ramadan MA, Califa AA. 1998. Acetophenones, a chalcone, a chromone and flavonoids from Pancratium maritimum. Phytochemistry. 49:2579–2583.
  • Zhang L, Lockeschwar BL. 2012. Medicinal properties of the Jamaican pepper plant Pimenta dioica and allspice. Curr Drug Targets. 13:1900–1906.